vs
Side-by-side financial comparison of BLACKLINE, INC. (BL) and IDEAYA Biosciences, Inc. (IDYA). Click either name above to swap in a different company.
IDEAYA Biosciences, Inc. is the larger business by last-quarter revenue ($207.8M vs $183.2M, roughly 1.1× BLACKLINE, INC.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs 2.7%, a 54.7% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $26.1M).
BlackLine Systems, Inc., is an American enterprise software company that develops cloud-based services designed to automate and manage the entire financial close process as well as consolidation, invoice-to-cash, and intercompany accounting. The Los Angeles–based company has 17 offices worldwide.
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
BL vs IDYA — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $183.2M | $207.8M |
| Net Profit | $4.9M | $119.2M |
| Gross Margin | 75.2% | — |
| Operating Margin | 3.7% | 52.2% |
| Net Margin | 2.7% | 57.4% |
| Revenue YoY | 8.1% | — |
| Net Profit YoY | -91.3% | 330.1% |
| EPS (diluted) | $0.07 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $183.2M | — | ||
| Q3 25 | $178.3M | $207.8M | ||
| Q2 25 | $172.0M | — | ||
| Q1 25 | $166.9M | — | ||
| Q4 24 | $169.5M | — | ||
| Q3 24 | $165.9M | $0 | ||
| Q2 24 | $160.5M | $0 | ||
| Q1 24 | $157.5M | $0 |
| Q4 25 | $4.9M | — | ||
| Q3 25 | $5.3M | $119.2M | ||
| Q2 25 | $8.3M | — | ||
| Q1 25 | $6.1M | — | ||
| Q4 24 | $56.4M | — | ||
| Q3 24 | $17.2M | $-51.8M | ||
| Q2 24 | $76.7M | $-52.8M | ||
| Q1 24 | $10.8M | $-39.6M |
| Q4 25 | 75.2% | — | ||
| Q3 25 | 75.1% | — | ||
| Q2 25 | 75.2% | — | ||
| Q1 25 | 75.5% | — | ||
| Q4 24 | 75.6% | — | ||
| Q3 24 | 75.2% | — | ||
| Q2 24 | 74.9% | — | ||
| Q1 24 | 75.2% | — |
| Q4 25 | 3.7% | — | ||
| Q3 25 | 4.3% | 52.2% | ||
| Q2 25 | 4.4% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 3.7% | — | ||
| Q3 24 | 5.0% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 1.1% | — |
| Q4 25 | 2.7% | — | ||
| Q3 25 | 3.0% | 57.4% | ||
| Q2 25 | 4.8% | — | ||
| Q1 25 | 3.6% | — | ||
| Q4 24 | 33.3% | — | ||
| Q3 24 | 10.4% | — | ||
| Q2 24 | 47.8% | — | ||
| Q1 24 | 6.9% | — |
| Q4 25 | $0.07 | — | ||
| Q3 25 | $0.09 | $1.33 | ||
| Q2 25 | $0.13 | — | ||
| Q1 25 | $0.10 | — | ||
| Q4 24 | $0.79 | — | ||
| Q3 24 | $0.27 | $-0.60 | ||
| Q2 24 | $0.22 | $-0.68 | ||
| Q1 24 | $0.17 | $-0.53 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $390.0M | $786.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $332.3M | $1.1B |
| Total Assets | $1.8B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $390.0M | — | ||
| Q3 25 | $419.9M | $786.9M | ||
| Q2 25 | $459.1M | — | ||
| Q1 25 | $479.5M | — | ||
| Q4 24 | $885.9M | — | ||
| Q3 24 | $725.3M | $920.0M | ||
| Q2 24 | $616.6M | $701.7M | ||
| Q1 24 | $331.4M | $698.8M |
| Q4 25 | $332.3M | — | ||
| Q3 25 | $328.3M | $1.1B | ||
| Q2 25 | $414.0M | — | ||
| Q1 25 | $417.9M | — | ||
| Q4 24 | $446.7M | — | ||
| Q3 24 | $367.9M | $1.2B | ||
| Q2 24 | $325.8M | $931.7M | ||
| Q1 24 | $279.8M | $935.3M |
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.7B | $1.2B | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $1.8B | — | ||
| Q3 24 | $1.7B | $1.2B | ||
| Q2 24 | $1.9B | $973.7M | ||
| Q1 24 | $2.1B | $961.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.7M | $142.2M |
| Free Cash FlowOCF − Capex | $26.1M | $142.2M |
| FCF MarginFCF / Revenue | 14.2% | 68.4% |
| Capex IntensityCapex / Revenue | 0.3% | 0.0% |
| Cash ConversionOCF / Net Profit | 5.46× | 1.19× |
| TTM Free Cash FlowTrailing 4 quarters | $161.5M | $13.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.7M | — | ||
| Q3 25 | $63.8M | $142.2M | ||
| Q2 25 | $32.3M | — | ||
| Q1 25 | $46.7M | — | ||
| Q4 24 | $43.8M | — | ||
| Q3 24 | $55.9M | $-49.2M | ||
| Q2 24 | $40.7M | $-32.9M | ||
| Q1 24 | $50.4M | $-43.8M |
| Q4 25 | $26.1M | — | ||
| Q3 25 | $63.3M | $142.2M | ||
| Q2 25 | $31.4M | — | ||
| Q1 25 | $40.8M | — | ||
| Q4 24 | $43.0M | — | ||
| Q3 24 | $55.5M | $-49.7M | ||
| Q2 24 | $40.0M | $-33.9M | ||
| Q1 24 | $50.1M | $-45.1M |
| Q4 25 | 14.2% | — | ||
| Q3 25 | 35.5% | 68.4% | ||
| Q2 25 | 18.2% | — | ||
| Q1 25 | 24.4% | — | ||
| Q4 24 | 25.4% | — | ||
| Q3 24 | 33.5% | — | ||
| Q2 24 | 24.9% | — | ||
| Q1 24 | 31.8% | — |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | 0.0% | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 3.6% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 0.2% | — |
| Q4 25 | 5.46× | — | ||
| Q3 25 | 12.07× | 1.19× | ||
| Q2 25 | 3.90× | — | ||
| Q1 25 | 7.72× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | 3.24× | — | ||
| Q2 24 | 0.53× | — | ||
| Q1 24 | 4.66× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BL
| Subscription And Circulation | $173.2M | 95% |
| Technology Service | $10.0M | 5% |
IDYA
Segment breakdown not available.
